Examples of Price Concessions in a sentence
For guidance regarding the reporting of rebates and other price concessions for the RDS program, please see the RDS Program Guidance: Rebates and Other Price Concessions available on the CMS website at: https://www.cms.gov/Medicare/Prescription-Drug- Coverage/EmployerRetireeDrugSubsid/Downloads/20090112RebateGuidancePaper.pdf.II.
For PACE Organizations offering Part D coverage, reporting requirements will be limited to: Vaccines; Generic Drug Utilization; Pharmacy & Therapeutics (P&T) Committees / Provision of Part D Functions (for PACE Organizations utilizing formularies); Transition (for PACE Organizations utilizing formularies); Exceptions (for PACE Organizations utilizing formularies); Overpayment; Pharmaceutical Manufacturer Rebates, Discounts, and Other Price Concessions; and Long-term Care (LTC) Rebates.
For guidance regarding the reporting of rebates and other price concessions for the RDS program, please see the RDS Program Guidance: Rebates and Other Price Concessions available on the CMS website at: http://www.cms.hhs.gov/EmployerRetireeDrugSubsid/Downloads/20090112RebateGuidancePaper.pdf.II.
For PACE Organizations offering Part D coverage, reporting requirements will be limited to: Vaccines; Generic Drug Utilization; Pharmacy & Therapeutics (P&T) Committees (for PACE Organizations utilizing formularies); Transition (for PACE Organizations utilizing formularies); Exceptions (for PACE Organizations utilizing formularies); Overpayment; Pharmaceutical Manufacturer Rebates, Discounts, and Other Price Concessions; and Long-term Care (LTC) Rebates.
For guidance regarding the reporting of rebates and other price concessions for the RDS program, please see the RDS Program Guidance: Rebates and Other Price Concessions available on the CMS website at: https://www.cms.gov/Medicare/Prescription-Drug-Coverage/Employer RetireeDrugSubsid/Downloads/20090112RebateGuidancePaper.pdf.II.
Deriving Baseline Drug Expenditures Managed by PBMs 10Developing a Model of PBM Savings 12Evidence and Estimates 12Manufacturer Price Concessions and Pharmacy Discounts 12PBM Impact on the Use of Generics and Preferred Brands 14Utilization Management and Adherence Programs 17Administrative Efficiencies 20Projecting Limited/Average/Best-Practice PBM Savings 20Estimating the Cost of Jobs Covered by PBM Savings 22 I.
For guidance regarding the reporting of rebates and other price concessions for the RDS program, please see the RDS Program Guidance: Rebates and Other Price Concessions available on the CMS website at: http://www.cms.hhs.gov/EmployerRetireeDrugSubsid/Downloads/20090112RebateGuidancePap er.pdf.II.
Request for Information Regarding the Application of Manufacturer Rebates and Pharmacy Price Concessions to Drug Prices at the Point of Sales, 82 Fed.
Inclusion of Pharmacy Price Concessions in the Negotiated Price In the proposed rule, CMS states that it is considering for a future year, which could be as soon as 2020, adopting a new definition of “negotiated price.” The new definition would include all potential price concessions the plan sponsor could receive from the network pharmacy for a covered Part D drug.
For CY 2006, PACE organizations are limited to reporting data for the following sections: Enrollment/Disenrollment; Generic Dispensing Rate; Overpayment; Pharmaceutical Manufacturer Rebates, Discounts, and Other Price Concessions; Prior Authorization, Step Edits, Non-Formulary Exceptions, and Tier Exceptions (only for organizations utilizing formularies).